Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34077270

Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Jul 20
First author
Tolaney SM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Nov 10;39(32):3648-3649. doi: 10.1200/JCO.21.01967.
    note
    Source null
    related pmid
    34506210
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2021 Nov 10;39(32):3647-3648. doi: 10.1200/JCO.21.01716.
    note
    Source null
    related pmid
    34506214
    relationship
    Comment in

Authors and identifiers

  1. name
    Tolaney SM
    type
    Author
  2. name
    Tayob N
    type
    Author
  3. name
    Dang C
    type
    Author
  4. name
    Yardley DA
    type
    Author
  5. name
    Isakoff SJ
    type
    Author
  6. name
    Valero V
    type
    Author
  7. name
    Faggen M
    type
    Author
  8. name
    Mulvey T
    type
    Author
  9. name
    Bose R
    type
    Author
  10. name
    Hu J
    type
    Author
  11. name
    Weckstein D
    type
    Author
  12. name
    Wolff AC
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tolaney SM
    type
    Author
  2. name
    Tayob N
    type
    Author
  3. name
    Dang C
    type
    Author
  4. name
    Yardley DA
    type
    Author
  5. name
    Isakoff SJ
    type
    Author
  6. name
    Valero V
    type
    Author
  7. name
    Faggen M
    type
    Author
  8. name
    Mulvey T
    type
    Author
  9. name
    Bose R
    type
    Author
  10. name
    Hu J
    type
    Author
  11. name
    Weckstein D
    type
    Author
  12. name
    Wolff AC
    type
    Author
bibliography ids
  1. nci-bib-3d957946ba5d175653538d7e
book metadata
content sha256
d9491dc5a79e8f1540e068c3abb317d0a23c9098df5443be61cdb36d8a90676f
document type
citation
dois
  1. 10.1200/JCO.20.03398
electronic publication date
display
2021 Jun 2
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34077270
immutable id
pubmed:34077270@d9491dc5a79e8f1540e068c3abb317d0a23c9098df5443be61cdb36d8a90676f
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
21
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2375-2385
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Nov 10;39(32):3648-3649. doi: 10.1200/JCO.21.01967.
    note
    Source null
    related pmid
    34506210
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2021 Nov 10;39(32):3647-3648. doi: 10.1200/JCO.21.01716.
    note
    Source null
    related pmid
    34506214
    relationship
    Comment in
outcomes validated
false
pmid
34077270
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
3b393f6a2fa87904f94bed0e1a119b801d3a1c0d6b347133585bb3d475f52d11
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jul 20
precision
day
year
2021
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34077270/
title
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.

Preserved source evidence · Not medical advice